Singapore: European Medicines Agency (EMA) has nodded to review the marketing authorization application (MAA) of Enbrel ...
Singapore: Green Cross, South Korean biopharmaceutical company, is expanding its manufacturing base by building a new ce...
Singapore: Japan's pharmaceutical company, Eisai, has submitted its application to the regulatory authority in South Kor...
Singapore: Korea's Samsung Medical Center (SMC) has inked a pact with Elekta, a leading solutions provider for cancer an...
Singapore: In light of the recent outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV), WHO and Korea's M...
Singapore: AusBiotech and Korea Biotechnology Industry Organization (KoreaBIO) are signing a memorandum of understanding...
The annual list of Asia's fastest growing pharma companies, compiled painstakingly by the BioSpectrum Asia team, is out....
Singapore: The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyon...
Singapore: Pharmicell is commercializing Hearticellgram for acute myocardial infarction, Dong A Pharma has developed Car...
Singapore: Smart phones are the preferred tool for patient's engagement and communication with their healthcare provider...
Singapore: Montreal-based generic drug developer and marketer Pharmascience is venturing into Korea by forming a joint v...
Singapore: The Korean government announced plans to boost the fast growing biotech sector of Korea at the 11th President...
Before joining the family business of Green Cross in 1979, Mr Il-Sup Huh, the fifth son in the family, served the Korean...
Singapore: Dong-A Socio Holdings inaugurated their DM Bio plant dedicated to manufacturing biosimilar medicines and medi...
Singapore: Sigma-Aldrich's custom manufacturing and services business unit, SAFC, has signed an agreement with Seoul-bas...
According to the Global Burden of Disease and Risk Factors (World Bank Publications, 2006), infectious diseases are one ...
Many companies in India, China and to an extent Korea have established a strong position in contract manufacturing of ac...
In 2007, Dabur Pharma, one of India's leading manufacturers of anti-cancer drugs, launched Nanoxel, a novel drug deliver...
